News
Aug 04, 2017
Congratulations to Dr. Noel Warfel who was awarded a Lung Cancer Discovery Award, a one year $100,000 grant from the American Lung Association to fund his project “Targeting PIM kinases to Oppose Nrf2-driven Lung Cancers”
Jun 06, 2017
In a recent study led by UA Assistant Professor Casey Romanoski, PhD, the research team used genome-wide epigenetics to identify major drivers of human artery endothelial cell responses to inflammatory environments. They utilized endothelial genome sequences called enhancers to pinpoint DNA variation in humans that may underpin differential susceptibility to coronary artery disease.
May 17, 2017
Congratulations to Dr. Keith Maggert who has received the prestigious NIH Director’s Transformative Research Award, a five-year $1.7 million grant from the National Institutes of Health to fund his project “Induced transgenerational inheritance without epigenetics”.
Oct 26, 2016
Keith Maggert, PhD, with the University of Arizona Cancer Center and associate professor of cellular and molecular medicine, has been awarded a $1.7 million NIH grant and has been recognized for his high-risk/high-reward research that has the potential to change the way we think about epigenetics in disease.
Oct 04, 2016
To ensure researchers are competitive in their submission for national research funds to develop cures or new treatments for the world’s most pressing diseases, the UA Health Sciences has awarded four faculty members multidisciplinary program feasibility awards.
Oct 03, 2016
The college was honored with INSIGHT Into Diversity magazine’s 2016 Health Professions Higher Education Excellence in Diversity (HEED) Award.
Aug 04, 2016
House dust differences between Amish and Hutterite communities affect immune development and asthma risk, according to study co-authored by University of Arizona Health Sciences researcher Dr. Donata Vercelli published today in the New England Journal of Medicine.
Jul 18, 2016
Five-year National Heart, Lung, and Blood Institute program project grant led by UA Vice President for Health Sciences Dr. Joe G.N. “Skip” Garcia
Jun 29, 2016
Infecting between 50 to 80 percent of the population in the U.S. by the age of 40, the cytomegalovirus, known as CMV, is providing UAHS researchers with answers on how the incurable virus is able to lay dormant and then reactivate to become a life-threatening risk for those with inadequate immune systems.